Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast Cancer
CompletedOBSERVATIONAL
Enrollment
78
Participants
Timeline
Start Date
October 31, 2003
Study Completion Date
October 31, 2004
Conditions
Breast Neoplasms
Trial Locations (1)
20892
National Institute of Neurological Disorders and Stroke (NINDS), Bethesda
All Listed Sponsors
lead
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
NCT00071357 - Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter